Insights / July 03, 2019 / by beaconlbs

Featured Lab-of-Choice: AmeriPath

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, AmeriPath.

AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.

Through our nationally based, board certified pathology teams and integrated state-of-the-art laboratory, AmeriPath is dedicated to providing comprehensive diagnostic solutions, advanced technology and testing, and superior pathology services to regional and local medical communities. We deliver a clearer path to greater diagnostic insights.

Our team of over 450 highly trained, board-certified pathologists and Ph.D. level scientists provide medical diagnostic services in outpatient laboratories owned, operated and managed by AmeriPath, as well as hospitals and ambulatory surgical centers.

For more information, visit AmeriPath.com.

You Might Also Like:

Molecular Genetics / October 25, 2018 / by beaconlbs

Universal Tumor Testing for Lynch Syndrome – Why Does it Matter?

Lynch syndrome is responsible for up to 5% of colorectal cancer and endometrial cancer cases, and it is recommended that all related tumors been screened for the possibility of Lynch syndrome. Read more to learn about the benefits of universal tumor testin...

Insights / February 20, 2019 / by beaconlbs

The BeaconLBS Evidence-Based Process for Managing Lab Tests

BeaconLBS works with our health plan, employer and accountable care organization (ACO) partners to use evidence-based policies and guide lab test benefit management. Read about our four steps below.